This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Isracann Biosciences Beheer
Beheer criteriumcontroles 0/4
We currently do not have sufficient information about the CEO.
Belangrijke informatie
Ajay Kaila
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | 1.5yrs |
Eigendom CEO | n/a |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | geen gegevens |
Recente managementupdates
Recent updates
CEO
Ajay Kaila
1.5yrs
Tenure
Ajay Singh Kaila is Interim Chief Executive Officer of Isracann Biosciences Inc. from January 20, 2023.